C07D 263/00
Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
C07D263/00 (Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings) appears on 5,687 US grants and 4,494 published applications in this corpus.
Search patents in C07D- Granted patents
- 5,687
- Published applications
- 4,494
- Assignees
- 1,965
- Inventors
- 14,713
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 81 | 0 |
| 1977 | 115 | 0 |
| 1978 | 197 | 0 |
| 1979 | 84 | 0 |
| 1980 | 91 | 0 |
| 1981 | 106 | 0 |
| 1982 | 83 | 0 |
| 1983 | 63 | 0 |
| 1984 | 76 | 0 |
| 1985 | 71 | 0 |
| 1986 | 39 | 0 |
| 1987 | 67 | 0 |
| 1988 | 55 | 0 |
| 1989 | 85 | 0 |
| 1990 | 72 | 0 |
| 1991 | 73 | 0 |
| 1992 | 89 | 0 |
| 1993 | 116 | 0 |
| 1994 | 88 | 0 |
| 1995 | 99 | 0 |
| 1996 | 103 | 0 |
| 1997 | 137 | 0 |
| 1998 | 112 | 0 |
| 1999 | 134 | 0 |
| 2000 | 117 | 0 |
| 2001 | 152 | 32 |
| 2002 | 179 | 159 |
| 2003 | 162 | 202 |
| 2004 | 123 | 275 |
| 2005 | 102 | 251 |
| 2006 | 139 | 216 |
| 2007 | 129 | 211 |
| 2008 | 117 | 197 |
| 2009 | 115 | 231 |
| 2010 | 162 | 250 |
| 2011 | 127 | 209 |
| 2012 | 152 | 176 |
| 2013 | 163 | 171 |
| 2014 | 188 | 201 |
| 2015 | 162 | 183 |
| 2016 | 150 | 170 |
| 2017 | 154 | 158 |
| 2018 | 119 | 141 |
| 2019 | 129 | 162 |
| 2020 | 116 | 151 |
| 2021 | 92 | 145 |
| 2022 | 97 | 125 |
| 2023 | 89 | 181 |
| 2024 | 89 | 136 |
| 2025 | 75 | 96 |
| 2026 | 52 | 65 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Industrial synthesis of serinol6 Oct 2026US 12,753,146 B2Bracco Imaging S.P.A.
- Solid state form of tafamidis and a process for its preparation6 Oct 2026US 12,753,156 B2
- Capsaicin analogs and uses thereof29 Sep 2026US 12,747,200 B2Young BioPharma, LLC
- NAMPT modulators29 Sep 2026US 12,747,203 B2Cytokinetics, Inc.
- TEAD inhibitors29 Sep 2026US 12,747,207 B2Orion Corporation
- Oxazole trpml1 agonists and uses thereof1 Oct 2026US 2026/0297104 A1Libra Therapeutics, Inc.
- Hdac1/2 selective inhibitor and use thereof1 Oct 2026US 2026/0297110 A1Wigen Biomedicine Technology (Shanghai) Co., Ltd.
- Method for producing amide group-containing compound using n-carboxyamino acid anhydride24 Sep 2026US 2026/0285804 A1Chugai Seiyaku Kabushiki Kaisha
- Process for purifying 2-phenyl-4-(3-carboalkoxypropionyl)-1,3-oxazolin-5-one and new crystalline form b of 2-phenyl-4-(3-carbomethoxypropionyl)-1,3-oxazolin-5-one24 Sep 2026US 2026/0285820 A1Heraeus Precious Metals GmbH & Co. KG
- Linear dipeptidyl peptidase 1 inhibitors and uses thereof24 Sep 2026US 2026/0285821 A1
Most cited
By later US patents
- Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof1,998US 5,143,854 AAffymax Technologies N.V. · 1992
- Array of oligonucleotides on a solid substrate1,585US 5,445,934 AAffymax Technologies N.V. · 1995
- Arrays of materials attached to a substrate1,410US 5,744,305 AAffymetrix, Inc. · 1998
- Very large scale immobilized polymer synthesis967US 5,424,186 AAffymax Technologies N.V. · 1995
- Method of detecting nucleic acids962US 5,800,992 A1998